RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Crypto Researcher Says Post Ethereum’s Merge, Bitcoin Could Be ‘Regulated Away’
  2. Rockwell Climbs 7% As Earnings And Outlook Come In Better Than Consensus
  3. JPMorgan Chase Shares Rise 7% On Upbeat Q1 Results
  4. Baker Hughes Slips On Disappointing Q2 Results, Outlook
  5. $ETH: MicroStrategy CEO Michael Saylor Questions the Soundness of Ethereum